BCM
SBRA icon

Bayesian Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bayesian Capital Management’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,100
Closed -$224K – 1007
2022
Q3 		$224K Buy
+17,100
New +$253K 0.05% 501
2020
Q3 		– Sell
-11,907
Closed -$172K – 668
2020
Q2 		$172K Sell
11,907
-16,900
-59% -$222K 0.04% 449
2020
Q1 		$315K Buy
+28,807
New +$531K 0.07% 438
2018
Q2 		– Sell
-15,212
Closed -$268K – 711
2018
Q1 		$268K Buy
+15,212
New +$268K 0.07% 425

Other funds holding SBRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bayesian Capital Management's SBRA Position: Q4 2022 in Review

Bayesian Capital Management sold out of Sabra Healthcare REIT (SBRA) in Q4 2022, closing a stake of 17,100 shares — an estimated $224K sold.

Bayesian Capital Management first reported a position in SBRA in Q1 2018 and held it in 4 quarters. The position peaked at $315K in Q1 2020. 327 funds tracked by Wall St. Rank hold SBRA as of Q4 2022.

  • Bayesian Capital Management reported no remaining Sabra Healthcare REIT position as of Q4 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 17,100 Sabra Healthcare REIT shares in Q4 2022, an estimated $224K.
  • Bayesian Capital Management first reported a position in Sabra Healthcare REIT in Q1 2018 and held it in 4 quarters.
  • Bayesian Capital Management's Sabra Healthcare REIT position peaked at $315K in Q1 2020.
  • 327 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2022.

Based on Bayesian Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.